{"id":"NCT00411411","sponsor":"University Hospital, Gentofte, Copenhagen","briefTitle":"Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes","officialTitle":"Phase 3, Double Blinded, Placebo Controlled Study of the Effects of 12 Weeks DPP-IV Inhibitor Treatment on Secretion and Action of the Incretin Hormones in Patients With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-02","primaryCompletion":"2009-02","completion":"2009-03","firstPosted":"2006-12-14","resultsPosted":"2014-08-13","lastUpdate":"2014-08-13"},"enrollment":49,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Januvia","otherNames":["Sitagliptin"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Januvia","type":"EXPERIMENTAL"}],"summary":"We wish to evaluate the effect of long term treatment with a DPP-IV inhibitor on the function of the incretin hormones\n\nHypothesis We hypothesize that that a gradual improvement in metabolic control induced by DPP-IV inhibitor (JanuviaÂ®) treatment significantly ameliorates the impaired secretion and potency of GLP-1 and leads to a restoration of the lost action of GIP.","primaryOutcome":{"measure":"the Relative Increase in Meal-induced Total GLP-1 Secretion","timeFrame":"12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":2591,"sd":358},{"arm":"Januvia","deltaMin":3959,"sd":877}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":15},"locations":{"siteCount":1,"countries":["Denmark"]},"refs":{"pmids":["25243647"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}